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Myxoma virus was introduced into the European rabbit population of Australia in 1950. Although the virus was initially
highly lethal in rabbits, there was rapid selection for less virulent strains of virus and innately resistant rabbits. To investigate
the basis of resistance to myxoma virus, we have compared the pathogensis of the virulent strain of myxoma virus originally
released into Australia and an attenuated, naturally derived field strain of myxoma virus. This was done in laboratory rabbits,
which have not been selected for resistance, and in wild rabbits that have developed significant resistance. Wild rabbits were
able to recover from infection with virus that was always lethal in laboratory rabbits. Laboratory rabbits were able to control
and recover from infection with attenuated virus. This virus caused a trivial disease in wild rabbits. There was little difference
between laboratory and wild rabbits in titers of either virulent or attenuated virus in the skin at the inoculation site. However,
resistant wild rabbits had a 10- to 100-fold lower titer of virulent virus within the lymph node draining the inoculation site and
controlled virus replication in tissues distal to the draining lymph node. Replication of virus in lymphocytes or fibroblasts
cultured from wild and laboratory rabbits demonstrated that resistance was not due to altered cellular permissivity for
replication. Neutralizing antibodies were present in both susceptible and resistant rabbits, suggesting that these have no
significant role in resistance. We hypothesise that resistance is due to an enhanced innate immune response that allows the
rabbit to mount an effective cellular immune response. © 2000 Academic Press
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Infectious diseases have the potential to drive the
evolution of their hosts particularly when first introduced
into a naive host species. The pathogen may also evolve
to adapt to the new host. The best-documented studies
of the coevolution of a pathogen with a new mammalian
host species are from the release of myxoma virus into
the Australian wild rabbit population. However, despite
very detailed studies of the development of resistance in
the rabbit and attenuation of the virus, very little is un-
derstood about the mechanisms of either resistance or
attenuation (Anderson and May, 1982; Fenner, 1983; Kerr
and Best, 1998). This paper details studies on the basis
of resistance to myxoma virus in Australian wild rabbits.
Myxoma virus is a poxvirus (genus Leporipoxvirus)
naturally found in the jungle rabbit of South America
(Sylvilagus brasiliensis) or in the brush rabbit (S. bach-
mani) of North America. The virus is passively transmit-
ted by mosquitoes or other biting arthropods, and in its
natural hosts, it causes a cutaneous fibroma restricted to
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36the site of inoculation. However, European rabbits (Oryc-
tolagus cuniculus) infected with myxoma virus develop
the lethal, disseminated disease myxomatosis (Fenner
and Ratcliffe, 1965). The European rabbit is a major pest
species in Australia and, in an attempt at biological
control, the highly virulent Standard Laboratory (Moses)
Strain (SLS) of myxoma virus, originally isolated in Brazil,
was introduced into Australia in 1950. The results were
spectacular. Following its introduction, the virus spread
rapidly across the continent dramatically reducing rabbit
numbers and becoming endemic in the rabbit popula-
tion.
SLS initially was lethal in .99% of infected rabbits.
However, there was rapid selection for less virulent
strains of virus. Rabbits infected with these strains had a
longer survival time although they still killed #90% of
infected rabbits. Virus isolates from the field were graded
on a virulence scale of 1–5 based on the survival rate
and average survival times of small groups of infected
laboratory rabbits (Fenner and Marshall, 1957). Grade 1
viruses killed essentially 100% of infected rabbits with an
average survival time of ,13 days, grade 3 viruses killed
70–90% of infected rabbits with an average survival time
of 17–28 days, and grade 5 viruses killed ,50% of in-
fected rabbits. The strains of myxoma virus of interme-
diate (grade 3) virulence came to predominate in the field
as these were more efficiently transmitted by mosqui-
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37RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITStoes because the infected rabbits survived longer with
virus in the epidermis at or above the threshold titer for
efficient transmission (Fenner et al., 1956).
The emergence of attenuated virus strains facilitated
the natural selection of rabbits with enhanced innate
resistance to myxoma virus. These resistant rabbits rap-
idly came to dominate rabbit populations in Australia. As
an example, the survival rate of rabbits collected from a
single field site and challenged with a standard grade 3
strain of myxoma virus was increased from 10 to 74%
within 7 years of the first epidemic of myxomatosis (Mar-
shall and Fenner, 1958). A similar pattern of coevolution
of virus and host was observed following the release of
myxoma virus in Europe (Fenner and Ross, 1994).
The pathogenesis of myxomatosis in laboratory rab-
bits was described by Fenner and Woodroofe (1953).
Virus spreads from the initial replication site in the skin
to the lymph node draining the inoculation site and then
disseminates to other tissues such as spleen, lung, and
testis and to secondary sites in the skin and mucocuta-
neous junctions. Histologically the infected tissues show
a combination of cellular proliferation and cell death
(Hurst, 1937). However, the histological damage in criti-
cal tissues is not sufficient to explain the lethality of the
virus (Mims, 1964). Late in infection rabbits may develop
acute bacterial infections of the conjunctivae and upper
respiratory tract and these secondary infections have
been postulated as a cause of death (Hobbs, 1928).
However, in acute infections animals may die without
showing signs of significant secondary infection (Fenner
and Ratcliffe, 1965).
Like other poxviruses, myxoma virus encodes proteins
that modulate the immune response of the host. These
virulence factors include: a tumour necrosis factor bind-
ing protein (Upton et al., 1991), a gamma interferon bind-
ng protein (Upton et al., 1992), chemokine binding pro-
eins (Graham et al., 1997; Lalani et al., 1997), and pro-
eins such as M11L (Graham et al., 1992) and the serine
protease inhibitors Serp 1, which significantly reduce the
local inflammatory response (Macen et al., 1993), and
Serp 2, an inhibitor of interleukin-1b converting enzyme
Messud-Petit et al., 1998). At least four virulence genes
encode proteins that are critical for virus replication in
lymphocytes in vitro (Macen et al., 1996; Mossman et al.,
1996; Barry et al., 1997). In addition, myxoma virus infec-
tion downregulates expression of MHC-1 molecules on
the surface of infected cells (Boshkov et al., 1992) and
CD4 on infected lymphocytes (Barry et al., 1995).
Despite the emerging molecular detail about myxoma
virus, there have been no studies on the mechanism of
the resistance to myxoma virus that has developed in
wild rabbit populations in Australia and Europe (Kerr and
Best, 1998). This is important for understanding host-
virus coevolution and the use of myxoma virus as a
biological control agent. As a first step toward under-
standing resistance, we have compared the pathogene-sis of the virulent grade I SLS in wild and laboratory
rabbits with the pathogenesis of the attenuated grade 5
Uriarra strain (Ur) of myxoma virus, which was derived
from SLS within 2 years of the first field release (Mykyto-
wycz, 1953). Ur is usually nonlethal in laboratory rabbits
but causes clinically severe myxomatosis (Fountain et
al., 1997). Therefore it provides a useful model to exam-
ine recovery from myxoma virus infection. This paper
describes the differences in disease caused in each
group of rabbits, the replication of each virus in the skin
and lymphoid tissues of these rabbits, and the antibody
responses to these viruses. To determine whether resis-
tance is a function of cell permissivity for replication, we
examined the replication of myxoma virus in primary
cells prepared from both wild and laboratory rabbits.
RESULTS
Clinical disease and autopsy findings
All laboratory rabbits inoculated with SLS or Ur and
wild rabbits inoculated with SLS developed clinical myx-
omatosis. This was characterized by the development of
a large (6-cm diameter) red, elevated, primary skin lesion
at the site of inoculation followed by thickening of the
eyelids and the development of swellings (secondary
lesions) on the eyelids, nose, and ears and subsequently
over the entire body. Conjunctival inflammation and an
initially serous and later mucopurulent discharge from
the nose and eyes followed, accompanied by respiratory
distress and swelling and inflammation of the anogenital
region. Laboratory rabbits infected with SLS were not
kept beyond 10 days after inoculation as previous expe-
rience with this virus had shown that all animals died
between 10 and 14 days after infection (Robinson et al.,
1999). Wild rabbits inoculated with Ur had very mild signs
of myxomatosis. The time of onset (Table 1), and the
subsequent severity of clinical signs varied between
TABLE 1
Time Clinical Signs Were First Observed in Laboratory and Wild
Rabbits Inoculated with SLS or Ur Strains of Myxoma Virus
Clinical sign
Time of onset
Laboratory
rabbits Wild rabbits
SLS Ur SLS Ur
ink inoculation site Day 2 Day 3 Day 2 Day 4
onjunctival inflammation Days 4–6 Day 6 Day 5 Day 7–10
nogenital edema Day 6 Day 6 Days 5–7 Day 10
econdary lesions Day 6 Day 9 Day 7 Day 10
espiratory difficulty Day 7 Day 10 Days 9–12 —
esion regression — Day 17 Days 12–15 Day 15groups. Figure 1 shows typical animals from each group
with myxomatosis.
ly affec
38 BEST AND KERRLaboratory rabbits infected with Ur developed clin-
ical myxomatosis that was less severe than laboratory
rabbits infected with SLS (Figs. 1A and 1B). The symp-
toms and autopsy findings were similar to those seen
in wild rabbits infected with SLS. However, dissemi-
nated secondary lesions on the body were slower to
develop than in wild rabbits infected with SLS and
were not generalised until Day 1,5 and a scab had not
begun to form over the primary lesion until Day 17.
Recovery from infection was not as advanced at Day
20 in these rabbits as it was in wild rabbits infected
with SLS. The size of the primary lesion was similar to
SLS infected laboratory rabbits at ;6 cm diameter at
Day 10. In wild rabbits infected with SLS and labora-
tory rabbits infected with Ur, shrinkage of the testes
was noted late in infection, and several wild rabbits
had epididymal granulomas.
Wild rabbits infected with SLS developed similar clin-
ical signs to laboratory rabbits infected with SLS but the
FIG. 1. Clinical appearance of rabbits with myxomatosis. Laborator
with SLS at Day 10. The eyes are closed by a creamy mucopurulent dis
at the base of the ears (arrow). In (B), a rabbit infected with Ur shows
swellings at the base of the ear and on the nose (arrow). However, ther
infected with SLS at Day 10 with clinical signs similar to the laborator
signs at Day 10 (D). Wild rabbits infected with SLS became more severe
as IC at Days 15 and 20, respectively.severity was reduced and the onset was delayed (Fig.
1C). This was particularly the case with secondary le-sions, which were generally distributed over the body of
laboratory rabbits by 6 days after infection but took until
8 days to be generally distributed over the bodies of wild
rabbits. Similarly, respiratory distress was noted in lab-
oratory rabbits infected with SLS by 7 days after inocu-
lation but was delayed until 10 days in wild rabbits. One
wild rabbit inoculated with SLS died between Days 10
and 11. In this rabbit, the lungs were edematous and
blood filled. This was also the wild rabbit with the most
extensive primary and secondary lesions. At Day 10, all
the wild rabbits were depressed and had occulonasal
discharges. The primary lesions were extremely ele-
vated (2.5–3 cm high) and domed. Laboratory rabbits had
more severe clinical signs at this time including respira-
tory distress. At 12 days after infection all the wild rabbits
were experiencing respiratory difficulties; however, the
secondary and primary lesions had begun to scab over.
At 15 days after infection, the breathing had improved
and the scrotal oedema and anogenital inflammation
ts at 10 days after inoculation with SLS. (A) Laboratory rabbit infected
and there are secondary swellings around the nose (arrowhead) and
ar range of signs with swollen inflamed eyelids and conjunctivae and
ch less discharge from the eyes and the eyes are open. (C) Wild rabbit
t infected with Ur. Wild rabbits infected with Ur have very few clinical
ted until Day 12 and then began to recover. (E and F) The same rabbity rabbi
charge
a simil
e is mu
y rabbiwere reduced; by 20 days after infection the rabbits were
virtually recovered with scabbing of the primary lesion
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39RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITSand no mucopurulent discharge from nose or eyes (Figs.
1E and IF).
Wild rabbits infected with Ur developed a very mild
disease (Fig 1D) with the clinical signs mainly limited to
the primary lesion which were #4 3 2.5 cm (length 3
breadth). Secondary lesions were not a prominent fea-
ture with only one rabbit having a discrete secondary
lesion on an eyelid at 10 days after infection. Seven of
nine rabbits developed mild anogenital swelling and
scrotal edema by Day 10. At autopsy draining lymph
nodes and spleens were enlarged two to three times
normal size by Day 10, but contralateral nodes were not
enlarged until Day 15.
Rectal temperatures were elevated from Day 5 after
infection (Fig 2A). Temperatures decreased in the two
laboratory rabbits infected with SLS between Days 8 and
10. Temperatures in wild rabbits infected with SLS re-
mained .40°C until Day 13, rose again at Day 17, and
then declined toward normal. The temperatures of labo-
FIG. 2. (A) Rectal temperatures of rabbits inoculated with myxoma
irus. Temperatures were measured daily and are shown as the mean
or all animals in each group that were alive at each time point
temperatures were always measured prior to killing). For clarity, error
ars have been omitted. (B) Peripheral white cell counts for rabbits
noculated with myxoma virus. Total white cell counts per milliliter of
lood are shown as the mean for each group of animals. For clarity,
rror bars have been omitted.ratory rabbits infected with Ur followed a similar pattern
but were not consistently .40°C until Day 10. Wild rab-bits infected with Ur had a relatively mild temperature
elevation, which had returned to normal about Day 17.
Peripheral blood leukocyte counts were increased in
the SLS infected laboratory rabbits at 8 and 10 days after
infection (Fig 2B). This was due to an increase in the
numbers of circulating neutrophils with a reversal of the
neutrophil:lymphocyte ratio from 30:60 to 70:20. For the
other groups of animals there was little change in either
the absolute or differential leukocyte counts over the
course of the infection.
Myxoma virus titers in the skin
Virus was detected by plaque assay of the skin at the
inoculation site from all groups at 2 days after infection
(Figs. 3A and 3B). There was little difference in the titers
between Ur and SLS in either wild or laboratory rabbits.
The highest titers occurred by 6 days after infection in
both wild and laboratory rabbits and reached 109 pfu/g.
In laboratory rabbits infected with Ur, titres decreased to
104–106 pfu/g at Days 15 and 20. In wild rabbits, titers of
both Ur and SLS remained high (105–107 pfu/g) at Days
5 and 20.
Replication of myxoma virus in the skin is critical for
ransmission, and secondary lesions are an important
ource of virus for dissemination. In these experiments,
e measured virus titers in a skin site on the opposite
ind foot to that inoculated. All of the inoculated labora-
ory rabbits and all the wild rabbits inoculated with SLS
eveloped virus titers at this skin site (Figs. 3C and 3D).
n all but one case, only laboratory rabbits inoculated
ith SLS had virus titers above the 107 pfu/g transmis-
ion threshold in the distal skin. There was also a distinct
ifference between the virus types and the time at which
irus was detected in the distal skin. SLS was present in
istal skin of both laboratory and wild rabbits by 4 days
fter inoculation, but in Ur-inoculated laboratory rabbits,
irus was not detected until Day 6. A small amount of
irus was found in distal skin from wild rabbits inocu-
ated with Ur at 15 and 20 days but only in one of three
abbits at each time point.
eplication of myxoma virus in the lymph nodes
In laboratory rabbits infected with SLS or Ur, virus was
resent in the draining popliteal lymph node by Day 2
ith titres of 102–103 pfu/g (Fig. 4A). For laboratory rab-
its infected with SLS, virus titres were .107 pfu/g for
ive of the six rabbits harvested between Days 4 and 10
fter infection. By comparison laboratory rabbits infected
ith Ur generally had lower virus titres in the draining
ymph node with only one of six rabbits reaching titres of
107 pfu/g and only three of six having titres .106 pfu/g.
Ur was cleared from the draining lymph node by 15 days
after infection. One of two wild rabbits infected with SLS
had detectable virus at Day 2 in the draining lymph node;
however, at this time, virus was not detectable in the
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40 BEST AND KERRnodes from the Ur-infected wild rabbits (Fig. 4B). At 4
days after infection, all the wild rabbits infected with
either SLS or Ur had virus present in the draining lymph
node. In wild rabbits infected with SLS, virus titres in the
draining node were ,106 pfu/g. Although virus was de-
tectable in the node until Day 20, titers were ,105 pfu/g
rom Day 10 onwards. In general, wild rabbits had titres
f SLS 10–100 times lower than laboratory rabbits. In wild
abbits, Ur reached titres of 104 pfu/g, but by Day 10 only
ne of three rabbits had detectable virus in the draining
ode and no rabbits had detectable virus after Day 10.
Virus titers were also measured in the popliteal lymph
ode from the uninoculated hind leg (contralateral lymph
ode) as a measure of dissemination to and replication
n distal lymph nodes. In laboratory rabbits infected with
LS, virus was detected in the contralateral lymph node
y Day 4 after inoculation and in one of two Ur infected
abbits by Day 6 (Fig. 4C). Titers in the contralateral node
ere generally lower than those in the draining lymph
ode with SLS reaching a maximum of 8 3 105 pfu/g at
ay 6 and Ur 104 pfu/g. Virus was slower to reach this
node in wild rabbits with two of three rabbits inoculated
with SLS having detectable virus at Day 6. Ur was also
detectable at this time in wild rabbits, but titers remained
FIG. 3. (A) Myxoma virus titers in the skin at the site of inoculation o
at each time point are shown as a scatterplot. In addition, the geome
ndicates the mosquito transmission threshold (Fenner et al., 1956). (B) M
ith SLS (F) or Ur (E). (C) Virus titers in distal skin of laboratory rabbits
nfected with SLS (F) or Ur (E). For (C) and (D) the geometric mean tilow and the virus was undetectable by Day 15. One wild
rabbit infected with SLS had a titer .106 pfu/g, but SLS
o
oiters were generally 10–100 times lower than for labo-
atory rabbits (Fig. 4D).
yxoma virus in the spleen and peripheral blood
ononuclear cells
In the laboratory rabbits infected with SLS, virus was
irst detected in the spleen with titres ,103 pfu/g at 4
ays after inoculation. One of two laboratory rabbits
nfected with Ur had detectable virus in the spleen at this
ime. SLS reached a maximum titer of 5 3 105 pfu/g at
Day 10, whereas Ur was 8 3 103 pfu/g at the same time
oint. Ur was not detected in the spleen after Day 10. In
ild rabbits, SLS was also present in the spleen at Day
but only in one of three rabbits. At 6 and 10 days after
nfection, all three wild rabbits had SLS in the spleen with
iters ranging from 103 to 5 3 104 pfu/g. In one wild rabbit,
SLS was still detectable in the spleen at Day 15, but it
was not detected at Day 20. Wild rabbits inoculated with
Ur had virus in the spleen at Days 6 and 10 only. Maxi-
mum titers were 3 3 103 pfu/g (Fig. 5A).
Virus was detected in peripheral blood mononuclear
cells of all SLS-infected laboratory rabbits from Day 4 to
10. Titers ranged from 5 to 10 pfu/106 cells (Fig. 5B). Virus
as detected in the peripheral blood mononuclear cells
atory rabbits infected with SLS (F) or Ur (E). The titers for each rabbit
an of all titers is shown as a solid line. The dashed line at 107 pfu/g
a virus titers in the skin at the site of inoculation of wild rabbits infected
d with SLS (F) or Ur (E). (D) Virus titers in the distal skin of wild rabbits
r is shown as a dashed line and SLS as a solid line.f labor
tric me
yxomf Ur-infected laboratory rabbits at Days 6 and 10 but
nly as an occasional plaque (detection level 5 2 pfu/106
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41RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITScells). Virus of either strain was only detected in blood
mononuclear cells from one wild rabbit. This was at Day
6 from a rabbit infected with SLS and the titer was 22
pfu/106 cells.
eplication of myxoma virus in lung
Respiratory distress is a major clinical feature of myx-
matosis. However, except in one case, the lungs ap-
eared relatively normal at autopsy. Virus was not de-
ected in lung tissue until Day 6, and the only infection to
each substantial titers in lung tissue was SLS in labo-
atory rabbits (Fig. 6). In all other groups, virus titers in
he lungs were ,103 pfu/g. Only two wild rabbits had
detectable virus in the lungs, and this was at Days 6 and
10 after inoculation with SLS.
Serum antibody responses to myxoma virus
The serum IgM, IgG, and neutralizing antibodies were
measured for each of the rabbits killed at each time point
(Table 2). Antibody was detectable from Day 6 but SLS
FIG. 4. (A) Virus titers in the draining lymph node of laboratory rabbit
are shown as a scatterplot. In addition, the geometric mean titers have b
in the draining lymph node of wild rabbits infected with SLS (F) or Ur (
LS (F) or Ur (E). (D) Virus titers in the contralateral lymph node of winduced higher levels of neutralizing antibodies earlier
than Ur in both wild and laboratory rabbits. Wild rabbitsinfected with SLS also produced much higher titers of
IgG antibodies to myxoma virus than either laboratory or
wild rabbits infected with Ur.
Cell permissivity to myxoma virus infection
To determine whether there was any difference in cell
permissivity for myxoma virus replication in wild and
laboratory rabbits, we prepared primary fibroblast cul-
tures and primary lymphoid cell cultures from three wild
and three laboratory rabbits and measured productive
infection of these cultures by SLS in terms of the titers of
virus produced following infection and the proportion of
cells infected. In primary fibroblasts infected with SLS at
an m.o.i. of 3, 95–100% of cells were infected as judged
by immunofluorescence staining for virus in cells from
both wild and laboratory rabbits. The virus titers (log10
mean 6 SE pfu/106 cells) in fibroblasts at 24 h were
6.2 6 0.3 for wild rabbits and 5.9 6 0.4 pfu for laboratory
rabbits; there was little difference in these titers at 48
and 72 h (data not shown). In primary lymphoid cells from
ted with SLS (F) or Ur (E). The titers for each rabbit at each time point
otted separately for SLS (solid line) and Ur (dashed line). (B) Virus titers
Virus titers in the contralateral node of laboratory rabbits infected with
its infected with SLS (F) or Ur (E).s infec
een pleither the lymph nodes or spleens, ;50% of the cells
were infected from either rabbit type at 24, 48, and 72 h
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42 BEST AND KERRafter infection, suggesting that there was a subset of
cells insusceptible to infection. Virus titers in cells from
lymph nodes were 5.5 6 0.4 in wild rabbits and 5.6 6 0.4
n laboratory rabbits at 24 h and similar titers occurred at
8 and 72 h. The titers in lymphoid cells prepared from
he spleens were similar to those in cells prepared from
he lymph nodes.
DISCUSSION
The pathogenesis of myxomatosis was examined at
wo levels. Firstly, the differences in virus replication
etween the attenuated Ur strain of myxoma virus and
he virulent SLS were examined in laboratory rabbits.
hese rabbits have never been selected for resistance to
yxomatosis and serve as a model for the Australian
ild rabbit population in 1950 when SLS was released.
e then compared virus replication in these laboratory
abbits with the same virus strains in rabbits from the
ild population, which have undergone selection for
esistance to myxomatosis for nearly 50 years. Because
FIG. 5. (A) Titers of myxoma virus in the spleen of laboratory rabbits
infected with SLS (F); laboratory rabbits infected with Ur (E); wild
rabbits infected with SLS (); wild rabbits infected with Ur (). The
titers for each rabbit at each time point are shown as a scatterplot. (B)
Titers of myxoma virus in the peripheral blood mononuclear cells of
laboratory rabbits infected with SLS (F); laboratory rabbits infected
with Ur (E); wild rabbits infected with SLS () and wild rabbits infected
with Ur (). The titers for each rabbit at each time point are shown as
a scatterplot.he genetics of the viruses were held constant, this
llowed direct comparison of the two rabbit populations.he use of two virus strains of markedly different viru-
ences provided a demonstration of the degree of ge-
etic resistance that has developed in the wild rabbit
opulation.
The low doses of virus (100 pfu), comparable to what
mosquito might deliver (Day et al., 1956), and the
selection of an inoculation site that was largely drained
by a single lymph node allowed a detailed examination
of the steps involved in viral dissemination, control, and
clearance. Some care needs to be taken in interpreting
these data. Firstly, outbred animals were used, and these
would not all have the same level of resistance to myx-
oma virus. Secondly, the scale of the experiments meant
that limited numbers of animals were used at each time
point, thus single time points may have a large variance.
However, the use of laboratory and wild rabbits and
virulent and attenuated virus strains at each time point
provided a very clear picture overall of where virus rep-
lication was controlled.
Resistance to myxomatosis was not an absolute event
but reflected a dialog between the host and virus. In
laboratory rabbits infected with an attenuated virus or in
wild rabbits, the advantage was shifted toward the host.
Thus in laboratory rabbits infected with Ur, the severity of
the clinical signs was reduced and their onset was
slower although the actual clinical signs were similar to
SLS infected rabbits. Similarly, wild rabbits infected with
SLS became quite ill, particularly between 10 and 15
days after infection, but then recovered quickly from Day
15. Wild rabbits infected with Ur did not become ill and
clearly were able to control the infection.
The rectal temperatures of laboratory rabbits infected
with SLS fell in the final 48 h of the experiment. This was
accompanied by an increased white blood cell count
predominantly due to a neutrophilia. These signs were
not seen in the otherwise quite ill laboratory rabbits
infected with Ur or in the wild rabbits infected with SLS.
FIG. 6. Virus titers in the lung of laboratory rabbits infected with SLS
(F) or Ur (E) and wild rabbits infected with SLS () or Ur (). The titers
for each rabbit at each time point are shown as a scatterplot. The
geometric mean titers are shown for SLS in laboratory rabbits as a
solid line, as a large dashed line for Ur in laboratory rabbits, and as a
medium dashed line for SLS in wild rabbits.
abbits
43RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITSBoth of these groups maintained elevated rectal temper-
atures, and recovery from myxomatosis was accompa-
nied by a gradual return to normal rectal temperatures.
During the initial stages of SLS replication, there was no
difference in rectal temperatures in wild or laboratory
rabbits. This demonstrated that an elevated body tem-
perature was not sufficient to control myxoma virus rep-
lication in tissues distal to the skin. In contrast, replica-
tion of myxoma virus on chick chorioallantoic mem-
branes was inhibited at temperatures over 39°C
(Marshall, 1959), and there is some evidence that atten-
uated strains of myxoma virus replicated less efficiently
than virulent strains at high temperatures in tissue cul-
ture (Ross and Sanders, 1979).
The replication and dissemination of SLS in laboratory
rabbits in these trials was similar to that described by
Fenner and Woodroofe (1953). Thus in our trials, virus
was present in the skin at the inoculation site and in the
lymph node draining this site by 48 h after inoculation. At
4 days, it was present in the contralateral lymph node,
spleen, peripheral blood mononuclear cells, and distal
skin. By Day 6, it was detectable in the lung. As previ-
ously suggested (Fenner and Woodroofe, 1953), this is
compatible with a spread in infected lymphocytes in the
lymph to the blood and hence to distal lymphoid tissues
as lymphocytes traffic through these and also to skin and
other tissues.
All groups of rabbits developed similar titers of virus in
the skin at the inoculation site. These titers were suffi-
cient for both SLS and Ur to have been transmitted by
mosquitoes from the primary lesions in wild and labora-
tory rabbits (Fenner et al., 1956). The similarity in titers
indicated that neither attenuation nor resistance were
initially strongly manifested within the skin. However,
histological studies showed that wild rabbits had a much
more pronounced inflammatory response than labora-
tory rabbits by Day 10 even though virus titers were
similar (S. M. Best and P. J. Kerr, in preparation) Resis-
T
Serum Antibody IgM and IgG Antimyxoma Virus Ti
in Laboratory and Wild Rabb
Day
Laboratory rabbits
SLS Ur
N IgM IgG N IgM
6a — 1.0b — — 1.7
10 2.5 2.4 2.7 1.4 2.1
15 — — — 3.4 3.5
20 — — — 3.5 3.2
a Antibody was not detectable before Day 6.
b Geometric mean log 10 titers for the two laboratory or three wild rtance was very evident at the distal skin site. In labora-
tory rabbits, SLS replicated to high titers in the distalskin, whereas in wild rabbits titers of SLS were 100-fold
lower. The attenuated Ur reached the distal skin later
than SLS and replicated to lower titers in both wild and
laboratory rabbits. The fact that the virus reached the
distal skin site but then was restricted in its amplification
suggests that there was a functional immune response
operating at this site between Days 4 and 6. Interestingly,
apart from one wild rabbit at one time point, titers in the
distal skin were too low for virus transmission to have
occurred except from SLS-infected laboratory rabbits.
The earliest evidence of control of virus replication in
wild rabbits compared to laboratory rabbits was in the
lymph node draining the inoculation site. In wild rabbits,
both SLS and Ur had 10- to 100-fold lower titers in this
node, as early as Day 4, compared to the same viruses
in laboratory rabbits. Although there was a suggestion
that Ur replicated less efficiently than SLS in the draining
node of laboratory rabbits, the difference between SLS
and Ur was quite clear in wild rabbits. The differences in
virus titers and time of detection in distal skin, contralat-
eral lymph node, and lung between wild and laboratory
rabbits and virulent and attenuated viruses indicated that
the draining lymph node was a critical organ for ampli-
fication and dissemination of myxoma virus. It appeared
that early control of myxoma virus replication in this
tissue rather than the skin was critical for the disease
outcome.
Despite differences in titers in tissues of wild and
laboratory rabbits, SLS replicated equally efficiently in
both lymphoid cells and fibroblasts prepared from labo-
ratory and wild rabbits. Thus the reduced titers of virus in
the lymph nodes and other tissues of wild rabbits were
not due to resistance of the wild rabbit cells to virus
replication. This implies that control of infection was due
to a more effective immune response in wild rabbit lymph
nodes and subsequent tissues compared to laboratory
rabbits. This must become effective between 2 and 4
days after infection when the lower titers of virus were
asured by ELISA and by Neutralization Assay (N)
ected with either SLS or Ur
Wild rabbits
SLS Ur
N IgM IgG N IgM IgG
1.8 1.7 0.8 — 1.1 —
3.1 2.9 3.4 1.7 2.7 1.2
3.1 2.9 4.4 1.6 2.4 3.4
3.5 2.8 4.7 3.2 2.1 3.9
killed at each time point.ABLE 2
ters Me
its Inf
IgG
—
2.4
3.7
3.5first observed. The virulent SLS was still able to persist in
the lymph nodes of some wild rabbits for the duration of
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44 BEST AND KERRthe experiment, suggesting that it was able to suppress
or avoid this response to some extent. However, the
attenuated Ur virus was quickly cleared from the wild
rabbit lymph nodes with only one of three rabbits having
detectable virus at Day 10 after infection.
Conceptually myxomatosis has been compared with
mousepox (Fenner and Woodroofe, 1953). Recovery from
mousepox virus infection in inbred strains of mice de-
pends on effective innate effectors such as NK cells,
macrophages, nitric oxide, and type I and type II inter-
ferons, as well as adaptive CTL responses (which re-
quire antigen specific T helper cells producing type-1
cytokines such as interferon-g) and antibody (O’Neill and
Brenan, 1987; Jacoby et al., 1989; Karupiah, 1998; Karu-
piah et al., 1993a,b, 1996). In particular, a Th1 cytokine
profile in lymph nodes (interferon-g, IL-2, IL-12, and IL-4)
was correlated with a rapid and effective antiviral re-
sponse whereas a Th 2 profile (IL-4) led to failure to
control the infection and death (Karupiah, 1998). In addi-
tion, clearance of virus from the skin required a different
subset of effector cells to that required for clearance
from other tissues (Karupiah et al., 1996). Similar results
have been obtained for other viruses in outbred animals;
for example; macaques infected with an attenuated sim-
ian immunodeficiency virus had a Th1 cytokine profile in
the lymph node, whereas those infected with a virulent
SIV had a Th2 profile (Zou et al., 1997).
In a simple conceptual model based around mouse-
pox, resistance to myxomatosis in wild rabbits could be
explained by selection for an enhanced innate immune
response to myxoma virus. Thus in resistant rabbits, the
virulent virus would not effectively suppress the initial
inflammatory response to infection even though the virus
produces the same modulators of the immune response
that induce a lethal infection in laboratory rabbits. This
would allow antiviral mediators such as interferons and
TNF-a to induce an antiviral immune response, which,
etween 2 and 4 days after infection, limited the ampli-
ication of the virus at the draining lymph node. Devel-
pment of an NK cell response at this site and in other
issues would further limit viral replication and enhance
ntiviral cytokine production. Although some research-
rs have suggested that laboratory rabbits do not have
etectable NK cell activity (Laybourn et al., 1990), others
ave shown in vitro killing of vaccinia virus infected
enogeneic targets (Woan et al., 1978), suggesting that
K cell activity does occur in rabbits and therefore that
hese cells are likely to be important in control of virus
nfections.
Limiting the amplification of SLS and the associated
mmunosuppressive activities of the virus would allow a
ell mediated response specific for myxoma virus to
evelop, and this, as well as the innate, nonspecific
ntiviral response, could cause the effective control of
irus seen in distal lymphoid tissues, skin and lung of
ild rabbits. Because virus antigens will be presented toffector T cells earliest in the draining lymph node, we
uggest that events in this node are critical for develop-
ent of a T cell response for controlling virus replication
n other tissues.
Infection of laboratory rabbits with Ur provides a useful
ontrast to SLS. In our model, these laboratory rabbits
ave not been selected for the development of a strong
nnate response, but the lower virulence of the virus may
nable the animal to survive long enough to mount an
ffective immune response. The fact that lower virus
iters were not seen at the primary inoculation site in the
kin would fit with the evolution of myxoma virus to
eplicate predominantly within the skin of its native rabbit
osts rather than inducing a lethal disseminated infec-
ion (Fenner and Ratcliffe, 1965). Thus the virus is more
ffective at evading the host immune response within the
kin at the inoculation site rather than distally in other
issues. An interesting point is that Ur was slower to
each the draining lymph node in wild rabbits, suggest-
ng that it may also disseminate less efficiently from the
noculation site in these rabbits. This raises the ques-
ions of whether Ur then disseminates less efficiently to
ther tissues, whether the control of replication within
he draining lymph node prevents this dissemination, or
hether the development of an immune response simply
ontrols replication in tissues distal to the node. Further
tudies are needed to differentiate between these pos-
ibilities.
This highly simplified model makes specific, testable
redictions that will require the development of assays
or rabbit cytokines and cellular effectors. At this stage,
e have only examined antibody production in the im-
une response to myxoma virus infection. Antibody pro-
uction was not a good prognostic indicator as SLS-
nfected laboratory rabbits produced IgM and IgG and
ad neutralizing activity by 10 days after infection but
ould all have died. However, this showed that isotype
witching was occurring and thus that there was pre-
umably some T helper cell activity. The production of
igh levels of antibodies by laboratory rabbits infected
ith SLS could imply that the CD4 T cell response has
een predominantly Th2, dominated by IL-4, rather than
n antiviral Th1, dominated by interferon-g. However,
ild rabbits infected with SLS also produced high titers
f antibodies. In our proposed model, this could be
xplained by production of inteferon-g and a Th1 re-
sponse in wild rabbits. In a murine model, this would
lead to production of IgG2a and IgG3 rather than the Th2
induced IgG1 (Abbas et al., 1996). However, unlike spe-
cies such as rodents and humans, rabbits do not pro-
duce different IgG subclasses, in response to different
Th cytokine stimuli, as only one C-g heavy chain gene is
present (Knight and Crane, 1994), thus it was not possi-
ble to test whether a predominantly Th1 or Th2 response
was occurring based on the IgG subclasses.
The genetics of resistance to myxomatosis in rabbits
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45RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITShave not been investigated, but more than one locus is
likely to be involved (Kerr and Best, 1998). In mice, strain-
dependent resistance to mousepox is multigenic. The
main resistance locus Rmp-1 maps to the NK cell com-
lex on mouse chromosome 6 and may be identical to
mv-1, which encodes resistance to murine cytomega-
ovirus (Brown et al., 1997). Whether Australian wild rab-
its have enhanced resistance to other virus infections
r an enhanced propensity to develop such resistance
nd whether this resistance to myxomatosis leaves the
abbit more vulnerable to other parasites such as proto-
oa or helminths are unresolved questions. The lethality
f the calicivirus causing rabbit hemorrhagic disease for
oth laboratory and wild rabbits in Europe and Australia
uggests that resistance is likely to be myxoma virus
pecific. The specificity of resistance could be examined
y testing the resistance of Australian wild rabbits to
ther poxviruses such as the vaccinia virus-derived rab-
itpox virus.
At this stage, the genetic differences between Ur and
LS are not known. Restriction mapping of Ur and the
LS derived strain of myxoma virus “Glenfield” did not
eveal any restriction fragment length polymorphisms
Russell and Robbins, 1989). Subsequent studies have
emonstrated that restriction maps of Glenfield and SLS
re identical but SLS could be distinguished from Ur by
HaeIII polymorphism (P. J. Kerr and K. M. Saint, in
reparation). The conservation of the restriction maps
ndicates that large scale genetic rearrangements have
ot occurred in Ur but the genetic basis of attenuation
emains to be determined.
MATERIALS AND METHODS
iruses
The Standard Laboratory Strain of myxoma virus (SLS)
sed in this study was derived from a freeze-dried rabbit
issue stock prepared by Professor Frank Fenner (John
urtin School of Medical Research, Canberra, Australia)
n 1953. This was subsequently passaged twice in RK13
ells and twice in rabbits. The virus is of grade 1 viru-
ence (Fenner and Marshall, 1957), killing 100% of in-
ected rabbits with an average survival time of ,13 days,
nd this was confirmed prior to this study (Robinson et
l., 1999). The Uriarra (Ur) strain of myxoma virus was
erived from the Uriarra/2/53–1 isolate (Mykytowycz,
953) by Russell and Robbins (1989). It was passaged an
nknown number of times in CV-1 cells before we ob-
ained it and subsequently was passaged twice in Sirc
ells and twice in rabbits. This virus is of grade 5 viru-
ence, and .95% of laboratory rabbits recover from in-
ection but all develop clinically severe myxomatosis
Fountain et al., 1997; Kerr unpublished data).Virus stocks were prepared as homogenates from
estes harvested from laboratory rabbits 8–9 days after
g
Gntradermal inoculation with either SLS or Ur. Titers were
etermined by plaque assay on Vero cell monolayers.
issue culture
Vero cells were cultured in minimal essential medium
MEM, Gibco BRL) supplemented with 10% newborn bo-
ine serum, 2 mM L-glutamine, 200 units/ml penicillin,
nd 100 mg/ml streptomycin. Rabbit fibroblasts were
produced by explant outgrowth from pieces of tunica
vaginalis. Fibroblasts were cultured in MEM supple-
mented as above except that initially 25% fetal bovine
serum was used, and this was reduced to 10% after 5
days. Primary lymphoid cells were prepared from lymph
nodes and spleens by passing the minced tissues
through mesh screens (Kruisbeck, 1993). Cells were cul-
tured in RPMI 1640 supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, 200 units/ml penicillin, and 100
mg/ml streptomycin. Cell viability was assessed by
trypan blue exclusion and was usually .95%.
Infection of primary fibroblasts and lymphoid cells
from wild and laboratory rabbits
Primary fibroblasts were prepared from three wild and
three laboratory rabbits. SLS was inoculated at a m.o.i. of
3. There were three replicates for each rabbit at each
time point. The cells were harvested at 24, 48, and 72 h
and plaque assayed as for other tissues. Primary lym-
phoid cells, prepared separately from the popliteal lymph
nodes, and the spleens of the same rabbits used for
fibroblast cultures were infected with SLS at a m.o.i. of 3,
three replicates from each rabbit at each time point. At
24, 48, and 72 h, wells were harvested and virus titers
were determined by plaque assay.
To determine the proportion of cells infected, fibro-
blasts from each rabbit were seeded onto sterile glass
coverslips in 24-well plates and infected as before. At 24,
48, and 72 h, the cells were fixed for 5 min in ice-cold
acetone/methanol (1:1) at 4°C, washed twice in PBS,
blocked with 3% BSA/PBS at room temp for 60 min, and
incubated for 2 h at 37°C with 100 ml of a 1:200 dilution,
in 1% BSA/PBS, of monoclonal antibody 3B6E4, which
stains myxoma virus antigen in infected cells (Fountain
et al., 1997). Antibody binding was visualized by the
addition of goat anti-mouse IgG conjugated to FITC
(Boehringer Mannheim) and viewed with confocal mi-
croscopy. For lymphoid cells, the same process was
followed except the cells were harvested, fixed, and then
transferred onto poly-L-lysine coated slides using a cy-
ospin.
abbit breeding and housing
All animal experiments followed CSIRO/NHMRC
uidelines for animal usage and were approved by the
unaghlin animal experimentation ethics committee.
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46 BEST AND KERRLaboratory rabbits were bred at the Gungahlin animal
facility and were an outbred line of predominantly New
Zealand White stock. Wild rabbits were bred in the Gun-
gahlin animal facility, and the breeding stock was de-
rived from rabbits captured as kittens in the Canberra
district. The animals used for experiments were one to
two generations removed from the wild. There was no
selection for resistance to myxomatosis in the breeding
facility.
For experimental use all rabbits were housed in indi-
vidual cages in a temperature and light controlled animal
room. Standard rabbit pellets and water were provided
ad libitum and green vegetables were supplied weekly.
Shelters were provided in each cage as a refuge for the
wild rabbits.
Only male rabbits were used in the experiments, and
all rabbits were .4 months old.
Indian ink studies to establish draining lymph node
The popliteal lymph node was confirmed as the pre-
dominant node draining the inoculation site by injection
of 500 ml of Indian ink intradermally into the skin over the
etatarsal bones of both hind feet of three rabbits. The
abbits were killed 24 h later, and the popliteal, inguinal
nd prefemoral lymph nodes were dissected from each
eg and examined for ink staining. In five of six inocula-
ions, the popliteal node was the only node stained, in
ne case the popliteal node was heavily stained and
here was light staining on the cut surface of the inguinal
ode. A similar experiment was performed for intrader-
al inoculation of the skin over the midpoint of the
iceps femoris muscles of the thigh. In this experiment,
he major drainage was also to the popliteal nodes, but
here was staining of the inguinal node in two of the six
noculations and the prefemoral node in a separate two
f the six inoculations. The lymph node drainage was
urther examined by inoculation of SLS and Ur strains of
yxoma virus at each site and the virus titers measured
n the left and right popliteal lymph nodes and spleens.
his confirmed that the foot inoculation provided good
tepwise drainage of virus to the popliteal node, but that
irus inoculated into the thigh did not reach this node
irectly from the skin site but was found in equal titers in
eft and right popliteal nodes and spleen at 4–6 days
fter infection.
nfections and monitoring of rabbits
Laboratory rabbits were inoculated with 100 pfu of
ither SLS (8 rabbits) or Ur (12 rabbits) intradermally into
he skin over the metatarsal bones of the left hind foot.
abbits were examined daily and clinical signs and rec-
al temperatures recorded. Wild rabbits were inoculated
n the same way, but 16 rabbits were inoculated with
ach virus. Two laboratory rabbits infected with SLS
ere killed at each of 2, 4, 6, and 10 days after inocula-ion. Two laboratory rabbits infected with Ur were killed
t each of 2, 4, 6, 10, 15, and 20 days after inoculation. For
ild rabbit infections, two rabbits were killed at 2 and 4
ays after inoculation and three at 6, 10, 15, and 20 days
fter inoculation. Rabbits were randomly allocated to
illing times prior to inoculation and killed by an intrave-
ous overdose of barbiturate.
issue collection and processing
Approximately 25 ml of blood was collected by car-
iac puncture into a heparinized syringe immediately
ollowing death. At autopsy the skin inoculation site,
he left popliteal lymph node (draining lymph node),
ight popliteal lymph node (contralateral node), skin
rom the equivalent site on the right hind foot to the
noculation site (distal skin), spleen, and anterior lobes
f the lungs were collected. The tissues were trimmed
o remove fat, divided as necessary for further analy-
is, and weighed. Lymph nodes, spleens, and lung
amples were then chopped finely with scissors or
calpel blades and homogenized using a small pestle
n a 1.5-ml plastic tube. Tissue homogenates were
uspended in MEM as a 10 or 25% w/v suspension,
onicated (3 3 5 s cycles on ice) using a probe
onicator and freeze thawed twice. Skin samples were
haved of hair, washed in PBS, minced with a scalpel
lade, weighed, and resuspended in 1 ml of 0.1 mg/ml
ollagenase D (Boehringer Mannheim) and incubated
t 37°C for 90 min with frequent agitation. This was
ollowed by sonication and freeze thawing as for other
issues. The collagenase digestion was optimized us-
ng different concentrations of collagenase and incu-
ation times and did not reduce titers of virus when
ninfected skin samples were incubated with either
03 or 106 pfu of added virus.
Peripheral blood mononuclear cells were prepared
from blood collected when the rabbit was killed. The
whole blood was centrifuged (500 g, 20 min), serum was
removed and stored at 220°C for subsequent assay, and
the buffy coat was collected and resuspended in 4 ml of
PBS. This was layered over 3 ml of Ficoll–Paque (Phar-
macia) and centrifuged (400 g, 20 min). The mononuclear
cell layer at the Ficoll/PBS interface was collected and
washed twice in MEM before being counted and stored
at 270°C for subsequent plaque assay.
Virus titrations
Virus titers in tissue suspensions were measured by
plaque assay in duplicate on Vero cell monolayers. Titers
were expressed as the mean of the duplicate determi-
nations in pfu/g of tissue or for peripheral mononuclear
6cells as pfu/10 cells. Limits of detection were 100 pfu/g
or 1–2 pfu/106 cells.
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47RESISTANCE TO MYXOMA VIRUS IN EUROPEAN RABBITSELISA
ELISA for IgM and IgG antibodies to myxoma virus
were performed using twofold serum dilutions from 1:50
(Kerr, 1997). Endpoint titers were defined as the recipro-
cal of the dilution giving an OD (405 nm) 0.1 units above
the 1/100 dilution of the negative serum.
Plaque reduction neutralization assays
Plaque reduction neutralization assays were per-
formed on Vero cell monolayers as previously described
(Kerr, 1997) using constant virus concentration (;100
pfu) and twofold dilutions of heat inactivated serum (30
min, 56°C). Titers were the reciprocal of the lowest
dilution giving a $50% reduction of the number of
plaques obtained with normal serum.
Leukocyte counts and differential counts
Peripheral blood samples (0.5 ml) were collected from
the marginal ear vein of all rabbits every 48 h, diluted
1:10 in an aqueous solution of 2% (v/v) glacial acetic acid
and 0.01% (w/v) gentian violet, and leukocytes counted
using a hemocytometer. Differential leukocyte counts
were made on air dried films stained with Wright’s stain.
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